FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
Key Details
- 1FDA has approved the Targeted Real-Time Early Warning System for sepsis from researchers at Johns Hopkins, commercialized by Bayesian Health.
- 2The AI analyzes electronic health records to identify sepsis earlier than doctors traditionally can—often by 2 to 48 hours.
- 3System deployment in multiple hospitals reduced sepsis mortality rates by 18% and shortened hospital stays.
- 4Sepsis leads to over 250,000 deaths annually in the US and accounts for one in three in-hospital deaths.
- 5FDA clearance enables hospitals to bill Medicare/Medicaid under the New Technology Add-on Payment program.
- 6The solution demonstrates robust clinical AI integration with real-world hospital data for actionable guidance.
Why It Matters
The FDA's clearance of this early sepsis warning system marks a significant milestone for clinical AI adoption, demonstrating real-world impact on patient outcomes. It highlights how machine learning can augment clinical vigilance and potentially become part of standard hospital care, informing future radiology-AI solutions.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.